Israel and India sign trade agreement

Trade between Israel and India totaled $2.2 billion in 2004.

November 14, 2005 06:59
1 minute read.


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Finance Minister Ehud Olmert and India's Commerce and Industry Minister Kamal Nath signed an agreement over the weekend containing proposals for expanded economic cooperation and trade, the Industry, Trade and Labor Ministry said Sunday. Talks will continue towards reducing import duties on select products, as well as a standardization Israeli companies to participate in Indian government tenders, investment incentives, strengthening links between the countries' banking systems, and other issues. Olmert and Nath also agreed to provide $1 million each yearly to help fund the recently created India-Israel Research and Development Cooperation Initiative. Trade between Israel and India totaled $2.2 billion in 2004.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection